BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29130109)

  • 21. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5-WT1-E-cadherin signalling pathway in pancreatic ductal adenocarcinoma.
    Li J; Li H; Zhu W; Zhou B; Ying J; Wu J; Zhang H; Sun H; Gao S
    J Cell Mol Med; 2020 Jan; 24(2):1370-1382. PubMed ID: 31845546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
    FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
    Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
    Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma.
    Hang C; Gong C; Fang Y; Chen L; Zhu J
    J Mol Histol; 2021 Apr; 52(2):187-196. PubMed ID: 33394290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of diffuse panbronchiolitis critical region 1 gene promotes cell proliferation, migration and invasion in pancreatic ductal adenocarcinoma.
    Yan J; Chen G; Zhao X; Chen F; Wang T; Miao F
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1908-1914. PubMed ID: 29242154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laminin‑332 mediates proliferation, apoptosis, invasion, migration and epithelial‑to‑mesenchymal transition in pancreatic ductal adenocarcinoma.
    Huang C; Chen J
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.
    Pérez-Mancera PA; Rust AG; van der Weyden L; Kristiansen G; Li A; Sarver AL; Silverstein KA; Grützmann R; Aust D; Rümmele P; Knösel T; Herd C; Stemple DL; Kettleborough R; Brosnan JA; Li A; Morgan R; Knight S; Yu J; Stegeman S; Collier LS; ten Hoeve JJ; de Ridder J; Klein AP; Goggins M; Hruban RH; Chang DK; Biankin AV; Grimmond SM; ; Wessels LF; Wood SA; Iacobuzio-Donahue CA; Pilarsky C; Largaespada DA; Adams DJ; Tuveson DA
    Nature; 2012 Apr; 486(7402):266-70. PubMed ID: 22699621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TUFT1 regulates metastasis of pancreatic cancer through HIF1-Snail pathway induced epithelial-mesenchymal transition.
    Zhou B; Zhan H; Tin L; Liu S; Xu J; Dong Y; Li X; Wu L; Guo W
    Cancer Lett; 2016 Nov; 382(1):11-20. PubMed ID: 27566398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
    Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
    Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
    Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
    Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
    Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
    J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of RbAp48 knockdown on migration and invasion of human cervical cancer cell line MS751 in vitro].
    Zhong J; Yang X; Mai M; Wang D; Lv L; Rao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1564-9. PubMed ID: 26607076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deubiquitinating enzyme USP9X regulates metastasis and chemoresistance in triple-negative breast cancer by stabilizing Snail1.
    Guan T; Yang X; Liang H; Chen J; Chen Y; Zhu Y; Liu T
    J Cell Physiol; 2022 Jul; 237(7):2992-3000. PubMed ID: 35506169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ProNGF siRNA inhibits cell proliferation and invasion of pancreatic cancer cells and promotes anoikis.
    Xu J; Song J; Yang X; Guo J; Wang T; Zhuo W
    Biomed Pharmacother; 2019 Mar; 111():1066-1073. PubMed ID: 30841420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.